You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 27, 2025

Drug Price Trends for NDC 10337-0450


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 10337-0450

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
VEREGEN 15% OINT,TOP ANIP Acquisition Company, d/b/a ANI Pharmaceuticals, Inc. 10337-0450-03 30GM 925.44 30.84800 2022-07-15 - 2027-07-14 Big4
VEREGEN 15% OINT,TOP ANIP Acquisition Company, d/b/a ANI Pharmaceuticals, Inc. 10337-0450-03 30GM 925.44 30.84800 2022-07-15 - 2027-07-14 FSS
VEREGEN 15% OINT,TOP ANIP Acquisition Company, d/b/a ANI Pharmaceuticals, Inc. 10337-0450-03 30GM 925.44 30.84800 2023-01-01 - 2027-07-14 Big4
VEREGEN 15% OINT,TOP ANIP Acquisition Company, d/b/a ANI Pharmaceuticals, Inc. 10337-0450-03 30GM 925.44 30.84800 2023-01-01 - 2027-07-14 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 4 of 4 entries

Market Analysis and Price Projections for the Drug NDC: 10337-0450

Understanding the National Drug Code (NDC)

The National Drug Code (NDC) is a unique, 11-digit code assigned to each drug product, including finished drugs, unfinished drugs, and compounded drug products. The NDC is divided into three segments: the first five digits identify the labeler or manufacturer, the next four digits specify the product, and the last two digits indicate the packaging[4].

Identifying the Drug with NDC 10337-0450

To analyze the market and project prices for the drug with the NDC 10337-0450, we first need to identify the drug. The NDC Directory maintained by the FDA provides detailed information about each drug product, including its name, strength, dosage form, and marketing status[1].

Market Analysis

Drug Characteristics

  • Manufacturer and Labeler: The first five digits (10337) of the NDC identify the labeler or manufacturer. This information can be found in the FDA's NDC Directory.
  • Product Details: The next four digits (0450) specify the product, including its active ingredient, strength, dosage form, and route of administration.
  • Packaging: The last two digits indicate the packaging details.

Market Trends

The overall prescription drug market is expected to grow at a Compound Annual Growth Rate (CAGR) of 9% through 2030. This growth is driven by factors such as increased demand for healthcare services, advancements in pharmaceutical technology, and an aging population[3].

Competition and Pricing

The pricing of a drug is influenced by several factors, including the number of competitors in the market, the drug's efficacy, research and development costs, and financial negotiations between pharmaceutical supply chain entities. For instance, new brand-name drugs tend to be more expensive due to these factors, while generics are generally more affordable[5].

Price Projections

Historical Pricing Data

To project future prices, it is essential to analyze historical pricing data. This can be obtained from sources such as the FDA's NDC Directory, pharmaceutical market analytics platforms, or state-specific drug price transparency reports. For example, the Oregon Drug Price Transparency Program provides detailed reports on drug price increases and trends[5].

Factors Influencing Price Changes

  • Rebates and Co-pay Assistance Programs: These can significantly impact the final price of the drug to the consumer.
  • Research and Development Costs: High R&D costs are often passed on to consumers in the form of higher drug prices.
  • Market Dynamics: The presence of competitors and the drug's market share can influence pricing strategies.
  • Regulatory Changes: Changes in regulatory requirements or policies can affect drug pricing.

Projected Price Trends

Given the general trend of prescription drug market growth and the factors influencing drug prices, here are some projected price trends for the drug with NDC 10337-0450:

  • Short-Term Projections: If the drug is a brand-name product with limited competition, it is likely to experience price increases in line with the industry average, potentially ranging from 10% to 20% annually.
  • Long-Term Projections: Over the next few years, if generic versions of the drug become available or if there is increased competition, prices may stabilize or decrease. However, if the drug remains a high-demand, high-efficacy product with limited competition, prices could continue to rise.

Case Study: Similar Drugs

Analyzing the pricing trends of similar drugs can provide insights into potential price projections. For example, the pricing data for Linezolid (NDC 00054-0319) shows fluctuations over time but generally follows the industry trend of moderate annual increases[3].

Regulatory and Transparency Considerations

Regulatory requirements, such as those under the Prescription Drug Price Transparency Act, can impact how drug prices are reported and managed. Manufacturers must report significant price increases and new high-cost drugs, which can influence market dynamics and consumer perceptions[5].

Conclusion

The market analysis and price projections for the drug with NDC 10337-0450 depend on various factors, including the drug's characteristics, market trends, competition, and regulatory environment. Here are the key takeaways:

  • Market Growth: The prescription drug market is expected to grow significantly.
  • Pricing Factors: Rebates, R&D costs, market dynamics, and regulatory changes influence drug prices.
  • Price Projections: Short-term increases are likely, but long-term trends depend on competition and regulatory factors.

Key Takeaways

  • The NDC is crucial for identifying and tracking drug products.
  • Market trends indicate a growing demand for prescription drugs.
  • Pricing is influenced by multiple factors, including competition and regulatory requirements.
  • Historical data and similar drug analyses are essential for price projections.

FAQs

Q: What is the National Drug Code (NDC)? A: The NDC is a unique, 11-digit code assigned to each drug product, identifying the manufacturer, product details, and packaging.

Q: How do I find information about a drug using its NDC? A: You can use the FDA's NDC Directory to find detailed information about the drug, including its name, strength, and marketing status.

Q: What factors influence the price of prescription drugs? A: Factors include rebates, R&D costs, market competition, and regulatory changes.

Q: How can I project future prices for a prescription drug? A: Analyze historical pricing data, consider market trends, and evaluate the impact of regulatory and competitive factors.

Q: What is the significance of the Prescription Drug Price Transparency Act? A: This act requires pharmaceutical manufacturers to report significant price increases and new high-cost drugs, enhancing transparency and accountability in drug pricing.

Sources

  1. FDA's National Drug Code Directory - FDA
  2. MISSOURI SPECIALTY MAC NAME OF DRUG - Missouri Department of Social Services
  3. Latest drug prices and trends for NDC 00054-0319 - DrugPatentWatch
  4. National Drug Code - ResDAC
  5. Prescription Drug Price Transparency Results and Recommendations - Oregon Department of Consumer and Business Services

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.